PRAM-1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PRAM-1 monoclonal antibodies for research applications. PRAM-1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PRAM-1, or P53-regulated apoptosis, is a critical protein involved in the regulation of cell death and survival, playing a significant role in maintaining cellular homeostasis. PRAM-1 expression and activity are extensively studied in cancer research, as alterations in PRAM-1 function can contribute to tumor development and treatment resistance. Research has shown that PRAM-1 interacts with multiple signaling pathways involved in cell survival and death decisions. Understanding PRAM-1's role in cellular processes can reveal new approaches for therapeutic intervention. Investigating PRAM-1's molecular mechanisms helps identify potential drug targets for cancer treatment. PRAM-1 research continues to expand our understanding of cell death regulation and cancer biology. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge about PRAM-1 and its role in human health and disease.